Physician profile
Olubunmi Bolaji
NPI 1619100633
$1,279.09
in general payments reported to CMS, 2019-2025
21 companies · $444 in 2025
The $444 reported for 2025 was more than what 90% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.96 · 2022: $116 · 2023: $215 · 2024: $434 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $399.77 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $137.70 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $103.65 | 2022 | |
| Somnomed INC. | $99.68 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $88.75 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Lundbeck LLC | $70.35 | 2023-2025 | Rexulti |
| Glaxosmithkline, LLC. | $54.27 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $42.10 | 2021-2023 | |
| Cumberland Pharmaceuticals, INC. | $39.27 | 2024 | Kristalose |
| Idorsia Pharmaceuticals US INC | $32.54 | 2023 | Quviviq |
| Abbott Laboratories | $25.88 | 2021 | |
| Renalytix Ai, INC. | $23.94 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Corcept Therapeutics | $23.79 | 2025 | Korlym |
| Lilly USA, LLC | $22.75 | 2021 | |
| Pfizer INC. | $21.97 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.43 | 2023 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $18.32 | 2023 | |
| Phadia US INC. | $14.96 | 2023 | Immunocap |
| Axsome Therapeutics, INC. | $14.86 | 2024 | Auvelity |
| Medicomp INC | $13.49 | 2025 | Telepatch Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $12.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olubunmi Bolaji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.